Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Year's New Drugs.

Ann I. Graul

    Drug News & Perspectives
    |April 5, 2003
    PubMed
    Summary
    This summary is machine-generated.

    In 2001, 36 new drugs and diagnostic agents launched, with anti-infectives leading therapeutic areas. The United States dominated new product introductions, accounting for 43% of the global market.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Osteoporosis.

    Drugs of today (Barcelona, Spain : 1998)·2003
    Same journal

    New drug discovery and development in India.

    Drug news & perspectives·2013
    Same journal

    Are we living in the end of the blockbuster drug era?

    Drug news & perspectives·2010
    Same journal

    Molecule of the Month. TAK-875.

    Drug news & perspectives·2010
    Same journal

    Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

    Drug news & perspectives·2010
    Same journal

    Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

    Drug news & perspectives·2010
    Same journal

    Trioxaquines: hybrid molecules for the treatment of malaria.

    Drug news & perspectives·2010
    See all related articles

    Area of Science:

    • Pharmaceuticals and Therapeutics
    • Drug Discovery and Development
    • Market Analysis

    Background:

    • The pharmaceutical industry continuously introduces new chemical entities and biological drugs.
    • Diagnostic agents play a crucial role in modern healthcare.
    • Market dynamics significantly influence the accessibility and adoption of new medical products.

    Purpose of the Study:

    • To analyze the landscape of new drug and diagnostic agent market introductions in 2001.
    • To identify the leading therapeutic areas for new product launches.
    • To determine the key geographical markets for these introductions.

    Main Methods:

    • Data compilation of new chemical entities, biological drugs, and diagnostic agents reaching their first markets in 2001.

    Related Experiment Videos

  • Categorization of new products by therapeutic group.
  • Analysis of market penetration, focusing on geographical distribution.

    • Main Results:

    • Thirty-four new chemical entities/biological drugs and two diagnostic agents were introduced in 2001.
    • Anti-infective therapy was the most active therapeutic group with five new market introductions.
    • The United States was the leading market, with 15 new launches representing 43% of all new introductions.

    Conclusions:

    • The year 2001 saw significant activity in pharmaceutical and diagnostic product launches.
    • Anti-infectives emerged as a key focus area for new drug development.
    • The United States demonstrated a strong market presence for novel therapeutic and diagnostic agents.